Nektar Therapeutics NKTR Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Nektar Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's free cash flow margin?
- Nektar Therapeutics (NKTR) reported free cash flow margin of -366.6% in Q1 2026.
- How has Nektar Therapeutics's free cash flow margin changed year-over-year?
- Nektar Therapeutics's free cash flow margin decreased by 79.5% year-over-year, from -204.2% to -366.6%.
- What is the long-term trend for Nektar Therapeutics's free cash flow margin?
- Over 5 years (2020 to 2025), Nektar Therapeutics's free cash flow margin has grown at a 12.5% compound annual growth rate (CAGR), from -209.6% to -377.8%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.